Temisis Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 1

Temisis Therapeutics General Information

Description

Operator of a pre-clinical biotechnology company intended to focus on the development of novel and efficacious compounds. The company's proprietary and novel small-molecule pre-clinical programs have shown efficacy, orally and topically, to remit psoriasis symptoms but without the common side effects associated with existing treatments, thereby enabling its clients the treatment of inflammatory diseases with unmet needs.

Contact Information

Website
www.temisis.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 19 Avenue De La Foret De Haye
  • 54500 Vandeouvre-Les-Nancy
  • France
+33 03
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 19 Avenue De La Foret De Haye
  • 54500 Vandeouvre-Les-Nancy
  • France
+33 03

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Temisis Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Temisis Therapeutics‘s full profile, request access.

Request a free trial

Temisis Therapeutics Patents

Temisis Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-6945618-B2 Amide derivative of polycafe oil quinic acid, its production method and its use Inactive 26-Apr-2016
JP-2019515036-A Amide derivative of polycaffeoylquinic acid, process for its preparation and its use Active 26-Apr-2016
AU-2017256698-A1 Amide derivatives of polycaffeoylquinic acids, process for producing same and uses thereof Active 26-Apr-2016
AU-2017256698-B2 Amide derivatives of polycaffeoylquinic acids, process for producing same and uses thereof Inactive 26-Apr-2016
CA-3060365-A1 Amide derivatives of polycaffeoylquinic acids, process for producing same and uses thereof Pending 26-Apr-2016 C07C235/40
To view Temisis Therapeutics’s complete patent history, request access »

Temisis Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Temisis Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Temisis Therapeutics‘s full profile, request access.

Request a free trial

Temisis Therapeutics FAQs

  • When was Temisis Therapeutics founded?

    Temisis Therapeutics was founded in 2017.

  • Where is Temisis Therapeutics headquartered?

    Temisis Therapeutics is headquartered in Vandeouvre-Les-Nancy, France.

  • What is the size of Temisis Therapeutics?

    Temisis Therapeutics has 3 total employees.

  • What industry is Temisis Therapeutics in?

    Temisis Therapeutics’s primary industry is Drug Discovery.

  • Is Temisis Therapeutics a private or public company?

    Temisis Therapeutics is a Private company.

  • What is the current valuation of Temisis Therapeutics?

    The current valuation of Temisis Therapeutics is .

  • What is Temisis Therapeutics’s current revenue?

    The current revenue for Temisis Therapeutics is .

  • Who are Temisis Therapeutics’s investors?

    Financiere Hoche Bains and Plant Advanced Technologies PAT have invested in Temisis Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process